Market closedNon-fractional

Curis/CRIS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Curis

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Ticker

CRIS

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Lexington, United States

Employees

49

Curis Metrics

BasicAdvanced
$38M
Market cap
-
P/E ratio
-$8.63
EPS
3.35
Beta
-
Dividend rate
$38M
3.35
4.076
3.793
436.049
450.306
-34.27%
-39.26%
-207.29%
3.597
3.9
76.96
-0.894
-5.67%
-21.67%
-1.65%
-3.41%

What the Analysts think about Curis

Analyst Ratings

Majority rating from 6 analysts.
Buy

Curis Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-590.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2M
-23.08%
Net income
-$12M
0.85%
Profit margin
-590.00%
31.11%

Curis Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.39%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$2.40
-$2.13
-$2.03
-$2.05
-
Expected
-$2.36
-$2.33
-$2.11
-$2.12
-$1.67
Surprise
1.69%
-8.43%
-3.97%
-3.39%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Curis stock?

Curis (CRIS) has a market cap of $38M as of July 06, 2024.

What is the P/E ratio for Curis stock?

The price to earnings (P/E) ratio for Curis (CRIS) stock is 0 as of July 06, 2024.

Does Curis stock pay dividends?

No, Curis (CRIS) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Curis dividend payment date?

Curis (CRIS) stock does not pay dividends to its shareholders.

What is the beta indicator for Curis?

Curis (CRIS) has a beta rating of 3.35. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Curis stock

Buy or sell Curis stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing